Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology
By MedImaging International staff writers Posted on 03 Mar 2014 |
New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology.
A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are quantizations of electromagnetic and mechanical vibrations, respectively. Therefore, plasmons are collective oscillations of the free electron gas density, for example, at optical frequencies.
“Plasmonic nanostructures are of great current interest as chemical sensors, in vivo imaging agents, and for photothermal therapeutics,” explained David G. Cahill, a professor and head of the department of materials science and engineering at the University of Illinois at Urbana-Champaign (USA). “Applications in imaging and sensing typically involve the emission of light at a different wavelength than the excitation, or ‘secondary light emission.’ The interpretation of resonant secondary light emission in terms of fundamental processes has been controversial for 40 years. In this work, we point out that resonant electronic Raman scattering and resonant fluorescence may both be useful descriptions of the secondary emission. Better understanding of these principles and their limitations can result in improved biological and medical imaging modalities.”
Fluorescence is a comparatively familiar process by which light of one color or wavelength is absorbed by a material, such as an organic dye or a phosphor, and then light is emitted at a different color after a brief interval of time. In Raman scattering, the wavelength of light is shifted to a different color in an instantaneous scattering event. Raman scattering is not common in everyday life but is a critical tool of analytic chemistry.
“Light emission from plasmonic nanostructures at wavelengths shorter than the wavelength of pulsed laser excitation is typically described as the simultaneous absorption of two photons followed by fluorescence, which is used a lot in biological imaging,” explained Dr. Jingyu Huang, first author of the study, which was published online January 2014 in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). “However, we found that by modeling the emission as Raman scattering from electron-hole pairs can predict how the light emission depends on laser power, pulse duration, and wavelength. Since we understand more of the mechanism of this kind of light mission, we can help to design the biological and medical imaging experiments better, and at the same time we can also have more insight into the broad background of surface-enhanced Raman scattering, which is also related to this kind of light emission.”
Related Links:
University of Illinois at Urbana-Champaign
A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are quantizations of electromagnetic and mechanical vibrations, respectively. Therefore, plasmons are collective oscillations of the free electron gas density, for example, at optical frequencies.
“Plasmonic nanostructures are of great current interest as chemical sensors, in vivo imaging agents, and for photothermal therapeutics,” explained David G. Cahill, a professor and head of the department of materials science and engineering at the University of Illinois at Urbana-Champaign (USA). “Applications in imaging and sensing typically involve the emission of light at a different wavelength than the excitation, or ‘secondary light emission.’ The interpretation of resonant secondary light emission in terms of fundamental processes has been controversial for 40 years. In this work, we point out that resonant electronic Raman scattering and resonant fluorescence may both be useful descriptions of the secondary emission. Better understanding of these principles and their limitations can result in improved biological and medical imaging modalities.”
Fluorescence is a comparatively familiar process by which light of one color or wavelength is absorbed by a material, such as an organic dye or a phosphor, and then light is emitted at a different color after a brief interval of time. In Raman scattering, the wavelength of light is shifted to a different color in an instantaneous scattering event. Raman scattering is not common in everyday life but is a critical tool of analytic chemistry.
“Light emission from plasmonic nanostructures at wavelengths shorter than the wavelength of pulsed laser excitation is typically described as the simultaneous absorption of two photons followed by fluorescence, which is used a lot in biological imaging,” explained Dr. Jingyu Huang, first author of the study, which was published online January 2014 in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). “However, we found that by modeling the emission as Raman scattering from electron-hole pairs can predict how the light emission depends on laser power, pulse duration, and wavelength. Since we understand more of the mechanism of this kind of light mission, we can help to design the biological and medical imaging experiments better, and at the same time we can also have more insight into the broad background of surface-enhanced Raman scattering, which is also related to this kind of light emission.”
Related Links:
University of Illinois at Urbana-Champaign
Latest General/Advanced Imaging News
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
- AI Model Significantly Enhances Low-Dose CT Capabilities
- Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
- AI Reduces CT Lung Cancer Screening Workload by Almost 80%
- Cutting-Edge Technology Combines Light and Sound for Real-Time Stroke Monitoring
- AI System Detects Subtle Changes in Series of Medical Images Over Time
- New CT Scan Technique to Improve Prognosis and Treatments for Head and Neck Cancers
- World’s First Mobile Whole-Body CT Scanner to Provide Diagnostics at POC
- Comprehensive CT Scans Could Identify Atherosclerosis Among Lung Cancer Patients
- AI Improves Detection of Colorectal Cancer on Routine Abdominopelvic CT Scans
- Super-Resolution Technology Enhances Clinical Bone Imaging to Predict Osteoporotic Fracture Risk
- AI-Powered Abdomen Map Enables Early Cancer Detection
- Deep Learning Model Detects Lung Tumors on CT
- AI Predicts Cardiovascular Risk from CT Scans
- Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans
- New Technology Provides Coronary Artery Calcification Scoring on Ungated Chest CT Scans
Channels
Radiography
view channel
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read more
Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
Lung cancer continues to be the leading cause of cancer-related deaths worldwide. While advanced technologies like CT scanners play a crucial role in detecting lung cancer, more accessible and affordable... Read moreMRI
view channel
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read more
First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
Each year, approximately 800,000 people in the U.S. experience strokes, with marginalized and minoritized groups being disproportionately affected. Strokes vary in terms of size and location within the... Read moreUltrasound
view channel
Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a highly promising cancer treatment, especially for bloodborne cancers like leukemia. This highly personalized therapy involves extracting... Read more
Tiny Magnetic Robot Takes 3D Scans from Deep Within Body
Colorectal cancer ranks as one of the leading causes of cancer-related mortality worldwide. However, when detected early, it is highly treatable. Now, a new minimally invasive technique could significantly... Read more
High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis
Each year, approximately one million prostate cancer biopsies are conducted across Europe, with similar numbers in the USA and around 100,000 in Canada. Most of these biopsies are performed using MRI images... Read more
World's First Wireless, Handheld, Whole-Body Ultrasound with Single PZT Transducer Makes Imaging More Accessible
Ultrasound devices play a vital role in the medical field, routinely used to examine the body's internal tissues and structures. While advancements have steadily improved ultrasound image quality and processing... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more